Dr. Peter Gulick, D.O

NPI: 1255383238
Total Payments
$1.1M
2024 Payments
$90,136
Companies
25
Transactions
1,760
Medicare Patients
100
Medicare Billing
$6,786

Payment Breakdown by Category

Other$843,850 (80.3%)
Travel$122,865 (11.7%)
Consulting$48,470 (4.6%)
Food & Beverage$34,445 (3.3%)
Education$801.27 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $841,350 383 80.1%
Travel and Lodging $122,865 329 11.7%
Consulting Fee $48,470 18 4.6%
Food and Beverage $34,445 1,012 3.3%
Honoraria $2,500 1 0.2%
Education $801.27 17 0.1%

Top Paying Companies

Company Total Records Latest Year
ViiV Healthcare Company $371,354 473 $0 (2024)
Gilead Sciences, Inc. $322,319 612 $0 (2024)
Merck Sharp & Dohme LLC $142,244 172 $0 (2024)
Janssen Products, LP $76,829 102 $0 (2023)
ABBVIE INC. $72,123 201 $0 (2024)
GlaxoSmithKline, LLC. $48,741 55 $0 (2024)
Theratechnologies Inc. $9,914 14 $0 (2023)
SANOFI PASTEUR INC. $4,320 1 $0 (2021)
Janssen Biotech, Inc. $1,445 93 $0 (2023)
Janssen Scientific Affairs, LLC $378.31 10 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $90,136 137 Gilead Sciences, Inc. ($40,614)
2023 $140,759 200 ViiV Healthcare Company ($50,616)
2022 $168,360 219 ViiV Healthcare Company ($111,032)
2021 $77,432 139 ViiV Healthcare Company ($32,123)
2020 $83,855 160 ViiV Healthcare Company ($49,001)
2019 $213,426 333 ViiV Healthcare Company ($94,653)
2018 $127,102 280 Gilead Sciences, Inc. ($53,467)
2017 $149,361 292 Gilead Sciences Inc ($69,388)

All Payment Transactions

1,760 individual payment records from CMS Open Payments — Page 1 of 71

Date Company Product Nature Form Amount Type
12/19/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $20.82 General
12/10/2024 Gilead Sciences, Inc. Biktarvy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: HIV
12/04/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological) Travel and Lodging In-kind items and services $30.00 General
Category: VACCINES
11/13/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $17.42 General
Category: HIV
11/12/2024 ViiV Healthcare Company DOVATO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $975.00 General
Category: HIV
11/08/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $20.74 General
Category: INFECTIOUS DISEASE
11/08/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $1.69 General
Category: VIROLOGY
11/07/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $11.11 General
Category: VIROLOGY
11/06/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $27.51 General
Category: HIV
10/25/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.30 General
10/23/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $22.38 General
10/18/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $16.88 General
10/15/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $4.94 General
Category: HIV
10/13/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $19.28 General
Category: PSYCHIATRY
10/11/2024 ViiV Healthcare Company CABENUVA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,300.00 General
Category: HIV
10/09/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $36.87 General
10/04/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $12.02 General
Category: VIROLOGY
10/02/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $6.20 General
Category: HIV
10/01/2024 Gilead Sciences, Inc. Epclusa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,290.00 General
Category: HCV
09/27/2024 Gilead Sciences, Inc. Epclusa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,290.00 General
Category: HCV
09/26/2024 Gilead Sciences, Inc. Epclusa (Drug) Travel and Lodging In-kind items and services $1,051.90 General
Category: HCV
09/26/2024 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $22.54 General
Category: HCV
09/24/2024 Gilead Sciences, Inc. Epclusa (Drug) Travel and Lodging In-kind items and services $982.83 General
Category: HCV
09/24/2024 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $72.29 General
Category: HCV
09/20/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $18.46 General
Category: HIV

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 27 47 $4,860 $2,347
2022 2 30 51 $4,940 $1,920
2021 1 14 24 $2,400 $1,131
2020 2 29 37 $4,780 $1,388
Total Patients
100
Total Services
159
Medicare Billing
$6,786
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 14 28 $4,480 $2,187 48.8%
36415 Insertion of needle into vein for collection of blood sample Office 2023 13 19 $380.00 $159.60 42.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 17 28 $4,480 $1,852 41.3%
36415 Insertion of needle into vein for collection of blood sample Office 2022 13 23 $460.00 $68.28 14.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 14 24 $2,400 $1,131 47.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 14 19 $1,900 $712.18 37.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 15 18 $2,880 $675.90 23.5%

About Dr. Peter Gulick, D.O

Dr. Peter Gulick, D.O is a Internal Medicine healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255383238.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Gulick, D.O has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $90,136 received in 2024. These payments were reported across 1,760 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($841,350).

As a Medicare-enrolled provider, Gulick has provided services to 100 Medicare beneficiaries, totaling 159 services with total Medicare billing of $6,786. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Medical Oncology, Infectious Disease
  • Location Lansing, MI
  • Active Since 05/17/2006
  • Last Updated 04/08/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1255383238

Products in Payments

  • DOVATO (Drug) $206,812
  • Epclusa (Drug) $118,065
  • ISENTRESS (Drug) $62,878
  • CABENUVA (Biological) $62,072
  • Biktarvy (Drug) $51,453
  • SHINGRIX (Biological) $47,699
  • APRETUDE (Biological) $42,382
  • DELSTRIGO (Drug) $37,665
  • MAVYRET (Drug) $33,754
  • RUKOBIA (Drug) $31,995
  • Mavyret (Drug) $25,147
  • SYMTUZA (Drug) $23,257
  • Symtuza (Drug) $23,214
  • ZEPATIER (Drug) $21,004
  • PIFELTRO (Drug) $20,531
  • PREZCOBIX (Drug) $12,188
  • Veklury (Drug) $11,236
  • Sunlenca (Drug) $10,180
  • EGRIFTA (Drug) $7,405
  • Viekira (Drug) $7,064

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Lansing